Showing results (631-640 of 649) with videos related to

Sort By:
Pageof 65
Drugs & Aging|March 6, 2026
Advancing Vaccination Strategies for Older Adults: Insights of the Adult Immunization Board MeetingMarco Del Riccio, Stefania Maggi, Katarzyna Wieczorowska-Tobis, et al.
The Journal of Experimental Medicine|March 10, 2001
Aberrant in vivo T helper type 2 cell response and impaired eosinophil recruitment in CC chemokine receptor 8 knockout miceS W Chensue, N W Lukacs, T Y Yang, et al.
Elife|September 3, 2020
Integrating genotypes and phenotypes improves long-term forecasts of seasonal influenza A/H3N2 evolutionJohn Huddleston, John R Barnes, Thomas Rowe, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 14, 2016
Brief treatment with a highly selective immunoproteasome inhibitor promotes long-term cardiac allograft acceptance in miceEsilida Sula Karreci, Hao Fan, Mayuko Uehara, et al.
Science (New York, N.Y.)|October 16, 2012
Tissint martian meteorite: a fresh look at the interior, surface, and atmosphere of MarsH Chennaoui Aoudjehane, G Avice, J-A Barrat, et al.
Cancer Discovery|May 13, 2022
Tumor-Derived Lysophosphatidic Acid Blunts Protective Type I Interferon Responses in Ovarian CancerChang-Suk Chae, Tito A Sandoval, Sung-Min Hwang, et al.
Nature|August 6, 2025
RNA N-glycosylation enables immune evasion and homeostatic efferocytosisVincent R Graziano, Jennifer Porat, Marie Dominique Ah Kioon, et al.
BMC Veterinary Research|December 8, 2019
Detection of live M. bovis BCG in tissues and IFN-γ responses in European badgers (Meles meles) vaccinated by oropharyngeal instillation or directly in the ileumSandrine Lesellier, Maria-Laura Boschiroli, Jacques Barrat, et al.
Nature Medicine|August 21, 2007
Toll-like receptor 4-dependent contribution of the immune system to anticancer chemotherapy and radiotherapyLionel Apetoh, François Ghiringhelli, Antoine Tesniere, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 22, 2025
Efficacy and Safety of Obeldesivir in High-Risk Nonhospitalized Patients with COVID-19 (BIRCH): a Phase 3, Randomized, Double-Blind, Placebo-Controlled StudyAnca Streinu-Cercel, Antonella Castagna, Shan-Chwen Chang, et al.
Pageof 65